Supriya Lifescience Ltd 543434
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- INR 410.55
- Day Range
- INR 407.20–417.00
- 52-Week Range
- INR 214.45–423.50
- Bid/Ask
- INR 0.00 / INR 0.00
- Market Cap
- INR 33.09 Bil
- Volume/Avg
- 68,910 / 49,944
Key Statistics
- Price/Earnings (Normalized)
- 27.03
- Price/Sales
- 6.07
- Dividend Yield (Trailing)
- 0.15%
- Dividend Yield (Forward)
- 0.15%
- Total Yield
- 0.15%
Company Profile
Supriya Lifescience Ltd is a manufacturer of Active pharmaceutical Ingredients. It is focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 392
Comparables
Valuation
|
Metric
|
543434
|
524348
|
543748
|
|---|---|---|---|
Price/Earnings (Normalized) | 27.03 | 26.52 | 23.94 |
Price/Book Value | 4.39 | 3.86 | 2.81 |
Price/Sales | 6.07 | 1.77 | 2.55 |
Price/Cash Flow | 30.87 | 19.98 | 19.08 |
Price/Earnings
543434
524348
543748
Financial Strength
|
Metric
|
543434
|
524348
|
543748
|
|---|---|---|---|
Quick Ratio | 3.14 | 0.87 | 0.99 |
Current Ratio | 6.26 | 1.61 | 2.09 |
Interest Coverage | 192.48 | 8.39 | 16.39 |
Quick Ratio
543434
524348
543748
Profitability
|
Metric
|
543434
|
524348
|
543748
|
|---|---|---|---|
Return on Assets (Normalized) | — | — | — |
Return on Equity (Normalized) | — | — | — |
Return on Invested Capital (Normalized) | — | — | — |
Return on Assets
543434
524348
543748
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Vpcpxzswd | Plkf | $566.6 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Qwncssfmq | Whxhyl | $102.4 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Wjjfgmfw | Hynmn | $97.3 Bil | |
MRNA
| Moderna Inc | Xlhhgzrk | Xhxl | $41.3 Bil | |
ARGX
| argenx SE ADR | Knpwhzf | Lff | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Qdqpfptdf | Ldty | $21.0 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Vldmmfy | Pzvcgy | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Bszsykqt | Fckmsv | $15.4 Bil | |
RPRX
| Royalty Pharma PLC Class A | Fnwykcgzz | Qqrjnn | $12.6 Bil | |
INCY
| Incyte Corp | Wyyjpxm | Vjpzsl | $11.6 Bil |